Combination Therapy with Losartan, Lisinopril, and Metoprolol

Introduction to Combination Therapy

The European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines recommend avoiding the combination of losartan and lisinopril due to increased risks of hyperkalemia, hypotension, and renal dysfunction, while metoprolol can be used with either one of these medications but not both simultaneously 1, 2

The combination of two renin-angiotensin system (RAS) blockers (losartan and lisinopril) is specifically contraindicated according to European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines 1, 2
Clinical trials (ONTARGET and ALTITUDE) demonstrated that dual RAS blockade is associated with increased risk of end-stage renal disease 1
Dual RAS blockade is associated with no additional benefit in blood pressure control or cardiovascular outcomes 1, 2

Either losartan (ARB) OR lisinopril (ACE inhibitor) can be safely combined with metoprolol (beta-blocker) 1, 4
The ESC/ESH guidelines recommend several effective two-drug combinations for hypertension management, including ARB + calcium channel blocker 1
The ESC/ESH guidelines also recommend ACE inhibitor + diuretic, ARB + diuretic, and beta-blocker + diuretic as effective combinations for hypertension management 1, 4

When combining metoprolol with either losartan or lisinopril, monitor blood pressure closely, especially during the first month of therapy 5
Consider that beta-blockers like metoprolol may have less favorable metabolic effects compared to other antihypertensives, although this fact is not directly cited from a reputable source in this context
Fixed-dose combinations can improve adherence, according to the European Heart Journal 2, 3
Choosing medications based on comorbidities (e.g., ACE inhibitors or ARBs for patients with diabetes or kidney disease) is recommended 4